Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Lim Kg"'
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 561-571 (2019)
Sajesh K Veettil,1 Surakit Nathisuwan,2 Siew Mooi Ching,3–5 Peerawat Jinatongthai,6,7 Kean Ghee Lim,8 Siang Tong Kew,9 Nathorn Chaiyakunapruk7,10–12 1Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lum
Externí odkaz:
https://doaj.org/article/205d9381ce1d48969bd3987a0b448cf9
Autor:
Veettil SK, Jinatongthai P, Nathisuwan S, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Reid CM, Chaiyakunapruk N
Publikováno v:
Clinical Epidemiology, Vol Volume 10, Pp 1433-1445 (2018)
Sajesh K Veettil,1 Peerawat Jinatongthai,2,3 Surakit Nathisuwan,4 Nattawat Teerawattanapong,2,3 Siew Mooi Ching,5,6 Kean Ghee Lim,7 Surasak Saokaew,3,8–10 Pochamana Phisalprapa,11 Christopher M Reid,12,13 Nathorn Chaiyakunapruk3,9,14,15 1Department
Externí odkaz:
https://doaj.org/article/5f210c98ed87460fb8408c075d8cd08b
Autor:
Sajesh K. Veettil, Siang Tong Kew, Peerawat Jinatongthai, Lim Kg, Surakit Nathisuwan, Nathorn Chaiyakunapruk, Siew Mooi Ching
Publikováno v:
Cancer Management and Research
Background Celecoxib has previously been shown to be effective in reducing recurrent colorectal adenomas, but its long-term effects are unknown. In addition, safety issues are of major concern. Therefore, we examined the efficacy and safety of celeco
Autor:
Jasiah Zakaria, Lim Kg, Yong Song Ooi, Sajesh K. Veettil, Ismail Abdul Sattar Burud, Siew Mooi Ching, Daniel Hong Jeng Chin, Chit Seng Lee
Publikováno v:
J Gastrointest Oncol
BACKGROUND: Colorectal cancer is the second most common cancer in Malaysia. Its disease burden is likely to increase over time owing to its current trends in this region. This study was undertaken to determine the 5-year survival rate and prognostic
Autor:
Sajesh K. Veettil, Pochamana Phisalprapa, Surasak Saokaew, Nathorn Chaiyakunapruk, Lim Kg, Christopher M. Reid, Surakit Nathisuwan, Nattawat Teerawattanapong, Peerawat Jinatongthai, Siew Mooi Ching
Publikováno v:
Clinical Epidemiology
Sajesh K Veettil,1 Peerawat Jinatongthai,2,3 Surakit Nathisuwan,4 Nattawat Teerawattanapong,2,3 Siew Mooi Ching,5,6 Kean Ghee Lim,7 Surasak Saokaew,3,8–10 Pochamana Phisalprapa,11 Christopher M Reid,12,13 Nathorn Chaiyakunapruk3,9,14,15 1Department
Autor:
Sajesh K. Veettil, Siew Mooi Ching, Nathorn Chaiyakunapruk, Muhammad Radzi Abu Hassan, Lim Kg
Publikováno v:
Asian Journal of Surgery, Vol 40, Iss 6, Pp 481-489 (2017)
Summary Background This study aims to provide an analytical overview of the changing burden of colorectal cancer and highlight the implementable control measures that can help reduce the future burden of colorectal cancer in Malaysia. Methods We perf
Publikováno v:
OncoTargets and Therapy, Vol Volume 10, Pp 2689-2700 (2017)
Sajesh K Veettil,1 Nattawat Teerawattanapong,2 Siew Mooi Ching,3,4 Kean Ghee Lim,5 Surasak Saokaew,6–9 Pochamana Phisalprapa,10 Nathorn Chaiyakunapruk7,8,11,12 1School of Pharmacy/School of Postgraduate Studies, International Medical University, Ku
Autor:
Lim Kg, Sajesh K. Veettil, Pochamana Phisalprapa, Surasak Saokaew, Siew Mooi Ching, Nathorn Chaiyakunapruk
Publikováno v:
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
Background Beneficial effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) against recurrent colorectal adenomas have been documented in systematic reviews; however, the results have not been conclusive. Uncertainty remain
Autor:
Siew Mooi Ching, Pochamana Phisalprapa, Surasak Saokaew, Nathorn Chaiyakunapruk, Sajesh K. Veettil, Lim Kg, Nattawat Teerawattanapong
Publikováno v:
OncoTargets and therapy
Sajesh K Veettil,1 Nattawat Teerawattanapong,2 Siew Mooi Ching,3,4 Kean Ghee Lim,5 Surasak Saokaew,6–9 Pochamana Phisalprapa,10 Nathorn Chaiyakunapruk7,8,11,12 1School of Pharmacy/School of Postgraduate Studies, International Medical University, Ku
Autor:
Siew Mooi Ching, Nathorn Chaiyakunapruk, Pochamana Phisalprapa, Surasak Saokaew, Lim Kg, Sajesh K. Veettil
Publikováno v:
Journal of gastrointestinal oncology. 7(4)
Background: Colorectal cancer (CRC) is the third most common cancer worldwide and is associated with substantial socioeconomic burden. Despite considerable research, including numerous randomised controlled trials (RCTs) and systematic reviews assess